Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
39,817,308
-
Total 13F shares
-
2,284,355
-
Share change
-
+807,085
-
Total reported value
-
$3,952,129
-
Price per share
-
$1.80
-
Number of holders
-
20
-
Value change
-
+$1,392,212
-
Number of buys
-
14
-
Number of sells
-
4
Institutional Holders of MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (MAIA) as of Q2 2025
As of 30 Jun 2025 MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (MAIA) had 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,284,355 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Centric Wealth Management, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., STATE STREET CORP, NORTHERN TRUST CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, MARSHALL WACE, LLP, and Centerpoint Advisory Group.
This table shows 20 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.